Wagels Lisa, Votinov Mikhail, Radke Sina, Clemens Benjamin, Montag Christian, Jung Sonja, Habel Ute
Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, Uniklinik RWTH Aachen, Aachen, Germany.
Institute of Neuroscience and Medicine 10, Research Center Jülich, Jülich, Germany.
Hum Brain Mapp. 2017 Sep;38(9):4574-4593. doi: 10.1002/hbm.23685. Epub 2017 Jun 12.
Testosterone, a male sex hormone, has been suggested to partly explain mixed findings in males and females when investigating behavioral tendencies associated with the MAOA polymorphism. Prior studies indicated that the MAOA polymorphism represents a vulnerability factor for financial risk-taking and harm avoidance and that testosterone increases human risk-taking. We therefore assumed an interactive influence of the MAOA polymorphism and testosterone application on decision making and corresponding neural correlates in a risk and reward context. Stratified for the MAOA polymorphism (S =short, L =long), 103 healthy males were assigned to a placebo or testosterone group (double blind, randomized) receiving a topical gel containing 50 mg testosterone. During a functional MRI scan, the participants performed a sequential decision making task. Our results indicate that testosterone and the MAOA polymorphism jointly influence sequential decision making. The MAOA-S variant was associated with less automatic harm avoidance as reflected in response times on safe decisions. Moreover, after testosterone administration, MAOA-S carriers were more risk-taking. Overall activity in the anterior cingulate cortex, anterior insula and inferior frontal gyrus increased with growing risk for losses. In the anterior insula, testosterone administration mitigated this effect solely in MAOA-S carriers. This might be a reflection of an improved coping during risk-reward conflicts subsequently modulating risky decision making. While the molecular basis is not well defined so far, our results support the assumption of testosterone as a modulatory factor for previously reported sex differences of behavioral associations with the MAOA-S variant. Hum Brain Mapp 38:4574-4593, 2017. © 2017 Wiley Periodicals, Inc.
睾酮,一种雄性激素,在研究与单胺氧化酶A(MAOA)基因多态性相关的行为倾向时,被认为可以部分解释男性和女性研究结果的差异。先前的研究表明,MAOA基因多态性是金融冒险和伤害回避的一个易感性因素,并且睾酮会增加人类的冒险行为。因此,我们假设MAOA基因多态性和睾酮应用在风险与回报情境下对决策及相应的神经关联存在交互影响。根据MAOA基因多态性分层(S =短型,L =长型),103名健康男性被随机分配到安慰剂组或睾酮组(双盲),接受含有50毫克睾酮的外用凝胶。在功能性磁共振成像扫描期间,参与者执行了一个序贯决策任务。我们的结果表明,睾酮和MAOA基因多态性共同影响序贯决策。MAOA-S变异型与较少的自动伤害回避相关,这在安全决策的反应时间上有所体现。此外,给予睾酮后,MAOA-S携带者更倾向于冒险。随着损失风险的增加,前扣带回皮质、前岛叶和额下回的整体活动增强。在前岛叶,给予睾酮仅在MAOA-S携带者中减轻了这种效应。这可能反映了在风险-回报冲突期间应对能力的改善,随后调节了冒险决策。虽然目前分子基础尚未明确,但我们的结果支持了睾酮作为先前报道的与MAOA-S变异型行为关联的性别差异调节因子的假设。《人类大脑图谱》38:4574 - 4593,2017年。© 2017威利期刊公司。